CA1092122A - Morphine/apomorphine rearrangement process - Google Patents

Morphine/apomorphine rearrangement process

Info

Publication number
CA1092122A
CA1092122A CA291,508A CA291508A CA1092122A CA 1092122 A CA1092122 A CA 1092122A CA 291508 A CA291508 A CA 291508A CA 1092122 A CA1092122 A CA 1092122A
Authority
CA
Canada
Prior art keywords
alkyl
yield
process according
formula
apomorphine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA291,508A
Other languages
French (fr)
Inventor
Roman R. Lorenz
Edward D. Parady
William H. Thielking
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Application granted granted Critical
Publication of CA1092122A publication Critical patent/CA1092122A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

ABSTRACT OF THE DISCLOSURE

Apomorphine derivatives are prepared in improved yield by rearrangement of the corresponding morphine derivative in the presence of anhydrous orthophosphoirc acid under a partial vacuum.

Description

Z~LZ~

~his invention xelateæ to an improved procQ~s for preparing apomorphine and its derivatives by rearrange-ment o~ the corra~ponding mwrphine derivative.
Apomorphines are very valuable compounds or u~e in medicine as em~tics~ hypoten~ive agents and CNS stimu-lant~ (Archer, U.S~ Patent 3,717,643 patented ~ebruary 20, 1973) or in the treatment of Parkinqonism ~German Application
2,154,162, published May 3, 1973). While apomorphines have been succes~fully synthesized in the laboratory ~see for n example Sp~th and Hromatka, Ber. 62, 325 (1929); Avenarius and Pschorr~ BerD 62, 321 (19291, whose claim to a total ~,vnthesis has however been challenged by Gulland, Chem. and Indr 16~ 774 ~1938); Neumeyer et al., J. Med. Chem. 16, 1223 (1973) and Neumayer et al., J. Med. Chem. 16, 1228 (1973)]~ none of the methods so far devised are commercially feasible, since they all involve multiple synth~tic steps and ~urthermore ~equire resolution of optical isomers at some stage in the ~nthesi~0 The classical morphine/apo~
morphine rearrang~ment thu~ remains the most practical 2~ source of apomorphines, since derivatives of naturally occurring morphine or its relatives (e.g. heroin or codein~) are readily available, can be conveniently derivatized by ~imple chemical trans~ormations either prior or sub-sequent to rearrangement, and during rearrangement maintain the natural steric configuration of the only original asymmetric cen~er which i~ not destroyed by khe rearrangement.
The u~e of a variety o~ acids to effect the morphine/apomorphine type rearrangement by heating the corre-sponding morphine derivative with the acid is known, ~ luding S concentrated aqueous zinc chloride solutions [Mayer, Ber. 4, 121 128 (1871) - apomorphine (no yield given~; Matthiessen et al., Ann. 158, 131-135 (1871~ - apocodeine ~no yield given); German Patent 489,185, Frdl. 16 ~II), 2485-2486 (1927-1929) - apocodeine (25~ yield) and apomorphine ethyl ether ~2~ yield)~,concentrated hydrochloric acid [Matthiessen et alO, Proc. Roy~ SocO ~London) B17, 455-462 (1869) - apo-morphine (no yield given~0 anhydrous o~alic acid [Knorr et al3~ BerO 40, 3355-3358 (1907~ - apocodeine ~no yield given), Folker~, J~ Am. ChemD Soc, 58~ 1814-1815 ~1936~ -apocodeine (12.8% yield); Corrodi et alO ~ HelvO ChimO Acta.
38, 2038-2043 (1955) - norapocodeine ~13% yield~, 85~ or 90%
phosphoric acid with current of anhydrous hydrogen chloride passed through mixture ~Oparina, ~him Farm~ Promn 15, 18-19 (1934~, U~SDS~R~ Patent 40,981 ~January 31, 1935);
CoA~ 30~ 7285 ~1936~ - apomorphine (40-42%~; Hensiak, J~
Med, Chem~ 8, 557~559 (1965~ - N-allylnorapomorphine (46%
yield~]~ 85% phosphoric acid with current of nitrogen passed through mixture ~Koch et al., JO MedO Chem. 11, 977-981 ~1968) apocodeine (20% yield~, norapomorphine ~13~
yield), N-eth~lnorapomorphine ~36% yield~, N-propylnorapo-morphine ~37% yield), N-propargylnorapomorphine ~20~ yield), N-cyclopropylmethylnorapomorphine ~33% yield~, N-benzylnor-apomorphine (37~ yield), N~phenethylnorapomorphine ~16%
yield)], aqueous glacial phosphoric acid ~ ~PO3)n -See Merck Index-Eighth Edition, page 824~ ~Wright~ JO Chem,
-3-~o~z~zz SocO 25, 652-657 ~1872) - apomorphine (006% yield~] and glacial pho~phoric acid [Small et al", J, Org, Chem, 5, 334-349 (1940~ - apocodeine ~30~ yield~] 7 It has now been surprisingly found that apomor-phines, such as apomorphine it~elf or apocodeine, or norapo-morphine deriva~ive~, can be preparPd in vastly improved yield over wha~ was previ~u61y available u~ing prior art proces~es by heating a corresponding morphine or norm~rphine derivative with anhydrous orthophosphoric acid (H3PO~) under a partial vacuum at a temperature at which the rearrangement from the compound of Formula I to Formula II occurs, the pres~ure being selected with the temperature such that the orthophos-phoric acid does not appreciably evaporate during the course of the reaction~ The apomorphines and R2~norapomorphine~
:L5 prepared by the present proce~s are those having the Fo~nula I:

OH
R~

where Rl i8 hydrogen or lower-alkyl, and R2 i8 hydrogen, l~wer-alkyl, lower-alkenyl, lower-alkynyl, phenyl-lower-alkyl or cycloalkyl-lower-alkyl from corresponding morphine derivatives o~ the Formula II:

~ H oo~II
where Rl and R2 have the meaning~ given aboveO A
-4-3L0~2122 particularly pre~erred group of apomorphines and ~2-norapo-morphines prepared by the present process are those of ~ormula I, where R1 is hydrogen or lower alkyl; and R2 is lower-alkyl or phenyl-lower~alkyl~
~sc~ q//'1 The process of the invention is~carrie~ out by heating the compounds of Formula II~ in anhydrous ortho-phosphoric acid ~H3PO4~ at a temperature in the range from about 125 to 140C~ under a partial vacuum~ While the practical lower limit to the operable pressure that can be used cannot be precisely defined, the pressure and temperature obviously should be such that the phosphoric acid is not evaporated off during the course of the reaction.
: In practice it has been found that a vacuum obtained from a water aspixator vacuum pump ~i eO about 9 to 20 mm.Hg~
is entirely suitable~ In some instances~ the reaction mixture tends to froth in the early minutes of the reaction, and such frothing is best controlled by increasing the pressure slightly until the frothi.ng subsides. Thus it may be nece~sary to use pressures up to about 50 or 60 mm Hg in the early minutes of the reactionO The rearrangement is usually completed in about 12 25 minutes, and it is advantageous to terminate the reaction and work up the product as soon as the xearrangement is aomplete~ The course of the reaction ls readily followed by thin layer chromatography, and since the products of the reaction are all known, they can be identified, for example, by compaxison of their melting points with the known melting point value for the conpounds or by mixed melting point determinations a A~ used herein the term lower-alkyl means a Z~LZ2 saturated hydrocarbon group, which may be straight or branched, ~ontaining from one to five carbon atoms. The term thus includes, but i~ not limited to, methyl, ethyl, prop~l~ isopropyl, hutyl and amyl~
The term lower~aLkenyl means an unsaturated radical having one double bond~ which may be straight or branched, and containing from three to five carbon atoms.
The term thus incJ.udes, but is not limited to, l-t2-propenyl), 1-(2-meth~l-2-propenyl~ 3-meth~1-2-butenyll or 1-~2-butenyl~.
The term lower-alkynyl means an unsaturated radical having one triple bond~ which may be straight or branched, and containing from three to five carbon atoms.
The term thus includes, but is not limited to, 1-~2-propynyl), 1-~2-methyl-2 prop~nyl~ 3~methyl-2 butynyl~ or 1-~2-butynyl).
The term cycloalkyl means a saturated carbocyclic group c~ntaining from three to six ring carbon atoms as illustrated, for exampleO by cyclopropyl, cyclobutyl, cyclo-pent~l~ cyclohexyl, 2~methylc~cl~utyl or 4-ethylcyclohexyl~
The process of the present invention is illustrated b~ the following descriptionO
EXAMPLE
A series of morphine/apomorphine rearrangements was carried out under five sets of process conditions designed to compare the yields obtained under the conditions of the present invention tCondition D~ either as compared with conditions used in the prior art tCondition A Koch et al,) or under conditions designed to determine the effect of other single reaction parameters such as the =6-3L0~92~LZ2 nature oi the acid used (Condition B) or combinations of reac~ion parameters such as the use of nitrogen, a vacuum or anhydrous vs. 85% phosphoric acid (Conditions C and E). These reaction conditions are as follows:
Condition A- The starting material was heated with 85% orthophosphoric acid while passing a stream of nitrogen through the mixture.
Condition B- The starting material was heated with 85% orthophosphoric acid under water aspirator vacuum.
Condition C- The ~5% orthophosphoric acid was flushed with nitrogen while L
heating, and rearrangement was then carried out with heating under applica-tion of a water aspirator vacuum.

~ondition D- The starting material was heated with anhydrous orthophos-. .
phoric acid under a water aspirator vacuum.
Condition E- The starting material was heated with anhydrous orthophosphoric acid while passing a stream of nitrogen through the mixture.
In each case the starting material was added to the phospho-ric acid after the latter had been heated to 70C. When reaction was com-plete in each case, as indicated by thin layer chromatographic analysis, each reaction mixture was worked up according to a standard procedure which is described as follows: The reaction mixture was poured into 600 ml. of ice water and allowed to stand overnight. The working up includes hydrolysis of the phosphate ester formed (by the reaction with the phosphoric acid) by reaction of said ester with water, which hydrolysis is substantially the same as that carried out on the corresponding phosphate esters formed by the reac-tion with the 85% or 90% phosphoric acid as taught in Hensiak and Koch et al., acknowledged above. The mixture was then heated to boiling for fifteen minu~es, to insure complete hydrolysis of the phosphate esters, then cooled and poured slowly into 650 ml. of saturated brine. The aqueous layer was decanted from the gum which formed, and the gum was dis ''~;

lO9~Z2 solved in 400 ml~ o~ water and made ba3ic by the addition of sodium sulflteO ~h~ mixture wa~3 then extracted wi~h isopropyl acetate, the organic solution filtered, dried over anhydroua calcium sulfate and then acidified with ethereal hydrogen chlorideO The hydrochloride salt which thus ~ormed was collected, ~ecrystall1z~d from an appropriate solvent, identi~ied by its melting point and weighed, The re~ults obtained, expressed in terms of percent yield, are given in th~ following tabl~s where the react~on condition used, i~e~ Conditions "A"9"B","C","D", or "E", and the maximum temperature and the total time of heating are given.
Result~ obtained in a series of runs for the rearrangem~nt of N-propylnormorphine to N prop~lnorapo-morphine are given in the following table The product in 15 eaah case was recry~tallized from n-butanolO
Run CondO ~ ~ Yield __ __ 1 A 142~41 49~0 3 A 145~75 39 2 6 A 143/55 30.1 7 A 148/50 33.9 8 A 145/S0 13.2 9 A 145/4Q~ 33 9 10-1 A l45/4 ~ ¢a~ 9 4 11 A NoAo (b~ 15.4 12 A 145/20 24,1 13 A 145/25 16~3 14 A 140/18 23~6 AVERAGE YIELD

2 ~ 130/13 2~.3 AVERi~GE YIEI-D
C 130/10 41 . 6 2 C 130/13 ~2.5 1 D 130/15 53,5 z~z Run Cond 9 Max~C~/Time~min ~ % Yield __ _ ~ __ 2 D 128/13 40,6 7 D 130/15 48.6 8 D 128/16 49~1 9 D 130/15 58~6 ~ D 130~15 5191 AVERAGE YIELD~c) 1 E 150~25 22.6 2 E 150/25 21.8 AVERAGE YIELD ~
~a~ Two runs~ Yield based on combined products.
(b) Not available (c~ Does not include two runs in which products were worked up in a totally different manner than the standard procedure and atypical yields, 30,2 and 23,6% respectively, obtained.
Results ohtained for the rearrangement of codeine to apocodeine are given in the following tableO The product in each case was recrystallized from water, Run Cond~ ~ ~ % Yield 1 A 145/A5 19~7 2 A 145/45 17.2 3 A 140/4,0 18~3 ~VERAGE ~IELD ~
1 D 140/20 59~2 AVERAGE YIELD ~~
Resulks obtained in the rearrangement of morphine to apomorphine aré given in the following table. The products 35 in each case were recrystallized from isopropyl acetate/
diethyl ether.
Run Cond. ~ % Yield _~ ___ __ 1 A 140~45 10,0 2 A 140/45 14,0 ~VERAGE YIELD
1 D 130/14 58.4 2 D 130/15 54.6 AVERAGE YIELD ~5~5~~

~0~3Z~Z'~
Results obtalned ~or the rearrangement o~ N-phenethyl-normorphine to N-phenethylnorapomorphine are given in the following table~ The products in each case were recrystal-lized from isopro~l acetatejdiethyl ether.
Run Cond~MaxOT~C0 ~ % ~ield 1 A 138/45 25~4 2 ~ 138/~5 22Og AVERAGE YIELD ~

1 D 130/15 6~,0 2 D 130~15 68.0 AVERAGE YIELD ~

1 E 150j40 53,0 2 E NoA~ 61,0 3 1 E ~A~ 150/~5~
3~2 ~150/25 ~ 35.6 A~IERAGE YIELD ~3~
The~e results show thatO under the conditions of the instant proGess~ iOeO reaction Condition D, the yield obtained in the morphine~apomorphine rearrangement for a variety of morphine der~vatives is in the range ~rom about 48 66~, In contrast the conditions used in the ~rior art (i,eO Condition A -~ Koch et alO~ afford yields in the range from 12-28~o

Claims (8)

The embodiments of the invention in which an ex-clusive property or privilege is claimed are defined as follows:
1. A process for preparing an apomorphine or N-sub-stituted-norapomorphine derivative having the formula:
...I
where R1 is hydrogen or lower-alkyl; and R2 is hydrogen, lower-alkyl, lower-alkenyl, lower-alkynyl, phenyl-lower-alkyl or cycloalkyl-lower-alkyl which comprises heating a corresponding compound having the formula:

...II
where R1 and R2 have the meanings given above with anhydrous orthophosphoric acid under a partial vacuum at a temperature at which the rearrangement from the compound of Formula I to Formula II occurs, the pressure being selected with the temperature such that the orthophosphoric acid does not appreciably evaporate during the course of the reaction.
2. A process according to claim 1, for preparing a compound having the Formula I where R1 is hydrogen or lower-alkyl and R2 is lower-alkyl or phenyl-lower-alkyl from a corresponding compound of Formula II.
3. The process according to claim 1, where the re-action is carried out at a pressure of 9 to 20 mm.
4. A process according to any one of claims 1, 2 and 3, where the reaction is carried out at a temperature from 125°C. to 140°C.
5. The process according to claim 2, for preparing N-propylnorapomorphine from N-propylnormorphine.
6. The process according to claim 2, for preparing apocedeine from codeine.
7. The process according to claim 2, for preparing apomorphine from morphine.
8. The process according to claim 2, for preparing N-phenethylnorapomorphine from N-phenethylnormophine.
CA291,508A 1977-01-10 1977-11-22 Morphine/apomorphine rearrangement process Expired CA1092122A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75788877A 1977-01-10 1977-01-10
US757,888 1991-09-11

Publications (1)

Publication Number Publication Date
CA1092122A true CA1092122A (en) 1980-12-23

Family

ID=25049636

Family Applications (1)

Application Number Title Priority Date Filing Date
CA291,508A Expired CA1092122A (en) 1977-01-10 1977-11-22 Morphine/apomorphine rearrangement process

Country Status (14)

Country Link
JP (1) JPS5387359A (en)
AU (1) AU510976B2 (en)
BE (1) BE862389A (en)
CA (1) CA1092122A (en)
CH (1) CH624674A5 (en)
DE (1) DE2758954A1 (en)
DK (1) DK584077A (en)
FR (1) FR2376847A1 (en)
GB (1) GB1566049A (en)
IE (1) IE45922B1 (en)
LU (1) LU78790A1 (en)
NL (1) NL7714227A (en)
NZ (1) NZ185799A (en)
SE (1) SE7713456L (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3171561D1 (en) * 1980-05-08 1985-09-05 Univ Northeastern N-substituted aporphines, a method of inducing emesis and a method of controlling psychosis utilising the same
WO1990012574A1 (en) * 1989-04-25 1990-11-01 Northeastern University Dopamine agonist compounds
GB201915911D0 (en) * 2019-11-01 2019-12-18 Johnson Matthey Plc Process

Also Published As

Publication number Publication date
NZ185799A (en) 1979-12-11
NL7714227A (en) 1978-07-12
BE862389A (en) 1978-06-28
JPS5387359A (en) 1978-08-01
FR2376847A1 (en) 1978-08-04
SE7713456L (en) 1978-07-11
CH624674A5 (en) 1981-08-14
IE45922B1 (en) 1982-12-29
IE45922L (en) 1978-07-10
DK584077A (en) 1978-07-11
AU3101377A (en) 1979-06-07
AU510976B2 (en) 1980-07-24
GB1566049A (en) 1980-04-30
LU78790A1 (en) 1978-07-11
FR2376847B1 (en) 1980-08-22
DE2758954A1 (en) 1978-07-13

Similar Documents

Publication Publication Date Title
Galli et al. Ring-closure reactions. 7. Kinetics and activation parameters of lactone formation in the range of 3-to 23-membered rings
Reetz et al. Stereoselective synthesis of β‐amino alcohols from optically active α‐amino acids
Le Noble et al. Oxygen vs carbon alkylation of ethyl acetoacetate
EP0638575B1 (en) Method for the preparation of diorganodialkoxysilanes
DE2539324A1 (en) NEW MULTIHETEROMACROCYCLES
Shanzer et al. Stereospecific synthesis of. alpha.-amino-. beta.-hydroxy acids
Hirama et al. Use of the E-vinyloxyborane derived from S-phenyl propanethioate for stereospecific aldol-type condensation. A simplified synthesis of the prelog-djerassi lactonic acid
CA1092122A (en) Morphine/apomorphine rearrangement process
Bingham et al. Reaction of carbethoxynitrene with allenes
EP0026894B1 (en) Process for the preparation of erythro-alpha-2-piperidyl-2,8-bis (trifluoromethyl)-4-quinoline methanol
DE2149159A1 (en) Trimethylhydroquinone prepn - from 2,6,6-trimethyl-2-cyclohexene-1,4-
Ishihara et al. New organocuprate-induced reduction of the enol phosphate moiety in 1-[(diethoxyphosphinyl) oxy]-F-1-alkene-1-phosphonates: an efficient synthesis of (Z)-1-hydro-F-1-alkene-1-phosphonates
DE2814747A1 (en) ACID DEHYDRATION OF 9 ALPHA-HYDROXYANDROSTENDIONS
DE69110343T2 (en) Process for the preparation of prostaglandin analogues using organozirconium derivatives.
US3997593A (en) Organic compounds
DE2502919C2 (en) Cyclopentane derivatives, processes for their preparation, and pharmaceutical compositions containing them
Casey et al. Thermal decomposition of (erythro-2, 3-dimethylpentanoyl) pentacarbonylmanganese (I)
US4162361A (en) Morphine/apomorphine rearrangement process
DE60302309T2 (en) Preparation of 5-formyl-2-furylboronic acid
Dahlhoff et al. Boron compounds. 40. O-Ethylboranediyl derivatives of dulcitol
US4087621A (en) 7-{3-Hydroxy-2β-[4-hydroxy-4-(lower alkyl)-trans-1-octen-1-yl]-5-oxocyclopent-1α-yl}hept-5-cis-enoic acids and related compounds
EP0261160B1 (en) Alicyclic compounds
DE2807230A1 (en) PROCESS FOR THE PRODUCTION OF ALCOXYMETHYLSILAZANES
NO143346B (en) PROCEDURE FOR THE PREPARATION OF THYMOSIN ALFA / 1
Hocking A 5-PHOSPHAFULVENE WITTIG REAGENT

Legal Events

Date Code Title Description
MKEX Expiry